about
Development of an Enhanced Sensitivity Bead-Based Immunoassay for Real-Time In Vivo Detection of Pancreatic β-Cell DeathEarly alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy.Preexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual β-cell function in recent-onset type 1 diabetesPrediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.Minimal functional β-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients.Predictors of progression to Type 1 diabetes: preparing for immune interventions in the preclinical disease phase.Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and HLA-DQ Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 Diabetes.Potential of UCHL1 as biomarker for destruction of pancreatic beta cells.Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients.Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease:Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic Patients.Correction: Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.Predictive factors of allosensitization after immunosuppressant withdrawal in recipients of long-term cultured islet cell grafts.Evaluation of the Sebia Capillarys 3 Tera and the Bio-Rad D-100 Systems for the Measurement of Hemoglobin A1c.A novel LIPS assay for insulin autoantibodies.Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes.Accelerated Progression to Type 1 Diabetes in the Presence of HLA-A*24 and -B*18 Is Restricted to Multiple Islet Autoantibody-Positive Individuals With Distinct HLA-DQ and Autoantibody Risk Profiles.An analytical comparison of three immunoassay platforms for subpicomolar detection of protein biomarker GAD65.SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipientsHLA-A*24 Carrier Status and Autoantibody Surges Posttransplantation Associate With Poor Functional Outcome in Recipients of an Islet AllograftA composite immune signature parallels disease progression across T1D subjectsCombined Analysis of GAD65, miR-375, and Unmethylated Insulin DNA Following Islet Transplantation in Patients With T1DImmune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review
P50
Q33569747-DD478C99-E869-4480-AF9A-29F395887E72Q35158250-7F29F8C3-1126-4757-8EBB-BC8609D7CB1AQ35207904-84EF6B03-EB6E-4C11-A5E2-96333881C835Q36209699-D1A79FA9-C331-43EE-983A-31A3A0E8EBE7Q37277940-741A7524-33F3-4C25-818D-3E2AB4FED154Q38161556-AB337CCC-2F07-4A80-9302-BEF66FD561FBQ38682088-865656ED-E107-450E-B88C-59A3E890BC74Q38914646-5F2BABEF-E7D8-4C81-B744-B4CCF4069531Q39096821-AFDFAE11-289A-44E3-A33A-8C2D431BC7FFQ39908057-D48B93BC-3A2B-4D8A-8879-7FF9C2BFAAD4Q41767345-4406B968-9773-4F3E-B3E1-2E7D2F7BF152Q42343992-3A320B72-198D-4DAE-8A7E-6F2BCE00201AQ44707440-1D1D495C-CE35-49ED-A5C6-625E532F9CE0Q47756501-B33C6AFA-B3EC-4CC4-A9F8-F486FB8EF7D0Q48300084-16AA6094-BB8A-4A4E-A32D-5D857E23BD0DQ49110588-829B57EC-8073-4318-AB86-4BD33DF335AFQ52653252-905878C6-BC92-4CD2-BF30-C42C185FE029Q55001318-E6ED6D95-BEF2-4F7C-938B-73A15C6A4AD7Q57177954-A161207E-9D4F-45F6-9936-3AEAB4C7D210Q89253116-C9A6C0CD-9726-4C6E-B432-221AB2F59F47Q91034625-F8F2E78F-F65F-4CD3-8041-C4F805BFA6D5Q91375214-3F770A37-E73A-42EE-9E21-E8C42E3509D6Q92079347-FD26709C-3F60-4888-B7AD-A4D4B1A9BCE2
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
F K Gorus
@en
F K Gorus
@nl
type
label
F K Gorus
@en
F K Gorus
@nl
prefLabel
F K Gorus
@en
F K Gorus
@nl
P31
P496
0000-0002-9007-6177